1. Week 96 resistance analyses of the once‐daily, single‐tablet regimen (STR) darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in adults living with HIV‐1 from the phase 3 randomized AMBER and EMERALD trials. Issue 6 (15th February 2021) Authors: Lathouwers, Erkki; Weinsteiger, Shirley; Baugh, Bryan; Ghys, Anne; Jezorwski, John; Mohsine, El Ghazi; Van Landuyt, Erika; De Meyer, Sandra Journal: Journal of medical virology Issue: Volume 93:Issue 6(2021) Page Start: 3985 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗